These findings suggest that GLP-1RAs may be beneficial against major adverse cardiorenal events in patients with type 1 diabetes, without compromising safety
Nat Rev Drug Discov 8:500515 Kooij KL, Koster DIj, Eeltink E et al (2024) GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling
Advert That's more than Mounjaro, which during clinical trials was found to lead to an average of 26.6 percent weight loss over 84 weeks, and Wegovy, which was found to help patients lose 19 percent of their body weight over 72 weeks
As you may have noticed, the 10mg lutein and 2mg zeaxanthin doses found in Astaxanthin+ mirror those used in several human studies.49 50 Importantly, researchers have also studied these carotenoids together
Protective role of chlorogenic acid against oxidative damage of ARPE-19 induced by blue light LED
Cell and gene therapy for kidney disease